• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Adaptive Biotechnologies Corporation - Common Stock (NQ:ADPT)

    14.79 -0.77 (-4.95%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 7, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 2,944,674
    Open 15.31
    Bid (Size) 14.81 (400)
    Ask (Size) 15.73 (100)
    Prev. Close 15.56
    Today's Range 14.53 - 15.37
    52wk Range 4.270 - 17.89
    Shares Outstanding 144,311,000
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Adaptive Biotechnologies to Participate in Upcoming Investor Conferences
    From Adaptive Biotechnologies
    Via GlobeNewswire
    Adaptive Biotechnologies Reports Third Quarter 2025 Financial Results
    From Adaptive Biotechnologies
    Via GlobeNewswire

    Performance

    YTD
    +138.9%
    +138.9%
    1 Month
    +3.1%
    +3.1%
    3 Month
    +17.9%
    +17.9%
    6 Month
    +59.5%
    +59.5%
    1 Year
    +157.2%
    +157.2%

    More News

    Read More
    Earnings Scheduled For November 5, 2025
    Via Benzinga
    Cathie Wood Goes All-In On Peter Thiel's Crypto Play Bullish With Back-To-Back Million-Dollar Buys
    Via Benzinga
    Earnings Scheduled For August 5, 2025
    Via Benzinga
    Adaptive Biotechnologies to Report Third Quarter 2025 Financial Results on November 5, 2025
    From Adaptive Biotechnologies
    Via GlobeNewswire
    Tesla To $300? Here Are 10 Top Analyst Forecasts For Monday
    Via Benzinga
    A Glimpse Into The Expert Outlook On Adaptive Biotechnologies Through 4 Analysts
    Via Benzinga
    United Natural Foods Posts Upbeat Results, Joins AnaptysBio, Semtech, UiPath And Other Big Stocks Moving Higher On Tuesday
    Via Benzinga
    Adaptive Biotechnologies to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
    From Adaptive Biotechnologies
    Via GlobeNewswire
    Adaptive Biotechnologies (NASDAQ:ADPT) Fits Minervini's Trend Template with Strong Growth Momentum
    Via Chartmill
    Why Adaptive Biotechnologies Stock Popped by Almost 6% on Wednesday
    Via The Motley Fool
    Adaptive (ADPT) Q2 Revenue Surges 36%
    Via The Motley Fool
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    Adaptive Biotechnologies Reports Second Quarter 2025 Financial Results
    From Adaptive Biotechnologies
    Via GlobeNewswire
    Cathie Wood's Ark Invest Loads Up On Absci, Offloads CRISPR Therapeutics
    Via Benzinga
    Adaptive Biotechnologies to Report Second Quarter 2025 Financial Results on August 5, 2025
    From Adaptive Biotechnologies
    Via GlobeNewswire
    Adaptive Biotechnologies and Flatiron Health Announce Integration of clonoSEQ® MRD Testing into OncoEMR®
    From Adaptive Biotechnologies
    Via GlobeNewswire
    Cathie Wood's Ark Invest Adds Airbnb, AMD, Shopify To Portfolio, Slashes Stake In Circle Internet
    Via Benzinga
    Assessing Adaptive Biotechnologies: Insights From 5 Financial Analysts
    Via Benzinga
    ADAPTIVE BIOTECHNOLOGIES (NASDAQ:ADPT) – A High-Growth Stock Meeting Minervini’s Trend Template
    Via Chartmill
    Cathie Wood's Ark Invest Continues To Offload Tesla As Elon Musk Moves On From Trump Administration
    Via Benzinga
    Topics Government
    Adaptive Biotechnologies Highlights New Data at 2025 ASCO Annual Meeting and EHA 2025 Congress Demonstrating How clonoSEQ® MRD Assessment is Optimizing Patient Care and Drug Development in Lymphoid Cancers
    From Adaptive Biotechnologies
    Via GlobeNewswire
    Adaptive Biotechnologies to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
    From Adaptive Biotechnologies
    Via GlobeNewswire
    ADAPTIVE BIOTECHNOLOGIES (NASDAQ:ADPT) – A Strong Growth Candidate Meeting Minervini’s Criteria
    Via Chartmill

    Frequently Asked Questions

    Is Adaptive Biotechnologies Corporation - Common Stock publicly traded?
    Yes, Adaptive Biotechnologies Corporation - Common Stock is publicly traded.
    What exchange does Adaptive Biotechnologies Corporation - Common Stock trade on?
    Adaptive Biotechnologies Corporation - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Adaptive Biotechnologies Corporation - Common Stock?
    The ticker symbol for Adaptive Biotechnologies Corporation - Common Stock is ADPT on the Nasdaq Stock Market
    What is the current price of Adaptive Biotechnologies Corporation - Common Stock?
    The current price of Adaptive Biotechnologies Corporation - Common Stock is 14.79
    When was Adaptive Biotechnologies Corporation - Common Stock last traded?
    The last trade of Adaptive Biotechnologies Corporation - Common Stock was at 11/07/25 04:00 PM ET
    What is the market capitalization of Adaptive Biotechnologies Corporation - Common Stock?
    The market capitalization of Adaptive Biotechnologies Corporation - Common Stock is 2.13B
    How many shares of Adaptive Biotechnologies Corporation - Common Stock are outstanding?
    Adaptive Biotechnologies Corporation - Common Stock has 2B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.